Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Richman

Showing results (181-190 of 210) with videos related to

Pageof 21
Sort By:
Cancer Immunology Research|September 26, 2014
Immune activation and a 9-year ongoing complete remission following CD40 antibody therapy and metastasectomy in a patient with metastatic melanomaDavid L Bajor, Xiaowei Xu, Drew A Torigian, et al.
Cancer|June 29, 2019
Phase 2 study of pembrolizumab and circulating biomarkers to predict anticancer response in advanced, unresectable hepatocellular carcinomaLynn G Feun, Ying-Ying Li, Chunjing Wu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 22, 2004
Pain education for underserved minority cancer patients: a randomized controlled trialKaren O Anderson, Tito R Mendoza, Richard Payne, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 22, 2011
Levels of symptom burden during chemotherapy for advanced lung cancer: differences between public hospitals and a tertiary cancer centerCharles S Cleeland, Tito R Mendoza, Xin Shelley Wang, et al.
Blood|January 7, 2017
Clinical and immunologic impact of CCR5 blockade in graft-versus-host disease prophylaxisRyan H Moy, Austin P Huffman, Lee P Richman, et al.
Plos One|June 28, 2016
Antifibrotic Effects of the Dual CCR2/CCR5 Antagonist Cenicriviroc in Animal Models of Liver and Kidney FibrosisEric Lefebvre, Graeme Moyle, Ran Reshef, et al.
Muscle & Nerve|July 4, 2019
Validation of the triple timed up-and-go test in Lambert-Eaton myastheniaShruti M Raja, Donald B Sanders, Vern C Juel, et al.
Transplantation and Cellular Therapy|October 1, 2021
Vitamin D deficiency after allogeneic hematopoietic cell transplantation promotes T-cell activation and is inversely associated with an EZH2-ID3 signatureRodney Macedo, Chloé Pasin, Alex Ganetsky, et al.
Neurology|July 1, 2016
International consensus guidance for management of myasthenia gravis: Executive summaryDonald B Sanders, Gil I Wolfe, Michael Benatar, et al.
Muscle & Nerve|December 28, 2017
3,4-diaminopyridine base effectively treats the weakness of Lambert-Eaton myastheniaDonald B Sanders, Vern C Juel, Yadollah Harati, et al.
Pageof 21

Showing results (181-190 of 210) with videos related to

Sort By:
Pageof 21
Cancer Immunology Research|September 26, 2014
Immune activation and a 9-year ongoing complete remission following CD40 antibody therapy and metastasectomy in a patient with metastatic melanomaDavid L Bajor, Xiaowei Xu, Drew A Torigian, et al.
Cancer|June 29, 2019
Phase 2 study of pembrolizumab and circulating biomarkers to predict anticancer response in advanced, unresectable hepatocellular carcinomaLynn G Feun, Ying-Ying Li, Chunjing Wu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 22, 2004
Pain education for underserved minority cancer patients: a randomized controlled trialKaren O Anderson, Tito R Mendoza, Richard Payne, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 22, 2011
Levels of symptom burden during chemotherapy for advanced lung cancer: differences between public hospitals and a tertiary cancer centerCharles S Cleeland, Tito R Mendoza, Xin Shelley Wang, et al.
Blood|January 7, 2017
Clinical and immunologic impact of CCR5 blockade in graft-versus-host disease prophylaxisRyan H Moy, Austin P Huffman, Lee P Richman, et al.
Plos One|June 28, 2016
Antifibrotic Effects of the Dual CCR2/CCR5 Antagonist Cenicriviroc in Animal Models of Liver and Kidney FibrosisEric Lefebvre, Graeme Moyle, Ran Reshef, et al.
Muscle & Nerve|July 4, 2019
Validation of the triple timed up-and-go test in Lambert-Eaton myastheniaShruti M Raja, Donald B Sanders, Vern C Juel, et al.
Transplantation and Cellular Therapy|October 1, 2021
Vitamin D deficiency after allogeneic hematopoietic cell transplantation promotes T-cell activation and is inversely associated with an EZH2-ID3 signatureRodney Macedo, Chloé Pasin, Alex Ganetsky, et al.
Neurology|July 1, 2016
International consensus guidance for management of myasthenia gravis: Executive summaryDonald B Sanders, Gil I Wolfe, Michael Benatar, et al.
Muscle & Nerve|December 28, 2017
3,4-diaminopyridine base effectively treats the weakness of Lambert-Eaton myastheniaDonald B Sanders, Vern C Juel, Yadollah Harati, et al.
Pageof 21